CD8A and neoplasm: In summary, iBMDMs not only have excellent macrophage function in vitro but also improve the tumor microenvironment in vivo, recruiting endogenous macrophages to exhibit an antitumor phenotype while reducing the proliferation of various tumor-promoting immune cells and increasing the number of antitumor CD8+ T cells, thus inhibiting tumor growth.